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Abstract We evaluated the effect of zinc treatment on the
blood–brain barrier (BBB) permeability and the levels of
zinc (Zn), natrium (Na), magnesium (Mg), and copper (Cu)
in the brain tissue during epileptic seizures. The Wistar
albino rats were divided into four groups, each as follows:
(1) control group, (2) pentylenetetrazole (PTZ) group: rats
treated with PTZ to induce seizures, (3) Zn group: rats
treated with ZnCl2 added to drinking water for 2 months,
and (4) Zn+PTZ group. The brains were divided into left,
right hemispheres, and cerebellum+brain stem regions.
Evans blue was used as BBB tracer. Element concentrations
were analyzed by inductively coupled plasma optical emis-
sion spectroscopy. The BBB permeability has been found to
be increased in all experimental groups (p<0.05). Zn con-
centrations in all brain regions in Zn-supplemented groups
(p<0.05) showed an increase. BBB permeability and Zn
level in cerebellum+brain stem region were significantly
high compared to cerebral hemispheres (p<0.05). In all
experimental groups, Cu concentration decreased, whereas
Na concentrations showed an increase (p<0.05). Mg content
in all the brain regions decreased in the Zn group and Zn+
PTZ groups compared to other groups (p<0.001). We also
found that all elements’ levels showed hemispheric differ-
ences in all groups. During convulsions, Zn treatment did
not show any protective effect on BBB permeability. Chronic
Zn treatment decreased Mg and Cu concentration and in-
creased Na levels in the brain tissue. Our results indicated that
Zn treatment showed proconvulsant activity and increased
BBB permeability, possibly changing prooxidant/antioxidant
balance and neuronal excitability during seizures.
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Introduction
The blood–brain barrier (BBB) protects the brain from the
toxic substances in the blood and ensures constant supply of
nutrients for neurons. But BBB structure could break down
in certain conditions like convulsive seizures [1]. In addition,
it was shown that asymmetrical changes in blood brain
barrier permeability between hemispheres and cerebellum+
brain stem regions during pentylenetetrazol induced seizures
in rats [2].
Epileptic seizures stronglymodify internal conditions with-
in the nervous tissue. There are many changes in neurotrans-
mitter release, gene activation, and elemental composition [3].
Moreover, it was reported that trace element concentrations
like magnesium (Mg), zinc (Zn), copper (Cu), and iron (Fe)
concentrations show changes during epileptic seizures. Ele-
ment contents determine susceptibility to convulsions [4].
BBB is important for Zn homeostasis in the brain. Defi-
ciency or excess of Zn has been shown to contribute to
alterations in behavior, abnormal central nervous system
development, and neurological disease [5]. Zn is a compo-
nent of more than 300 different enzymes that function in
many aspects of cellular metabolism, involving metabolism
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of proteins, lipids, and carbohydrates. The brain contains a
high concentration of Zn. It serves as a mediator of cell–cell
signalling in the central nervous system and alters behavior
of channels and receptors [6]. Zn passes into portal blood
and is transported. The transport of Zn into the brain paren-
chyma occurs via the brain barrier system, i.e., the BBB—
cerebrospinal fluid barriers. Studies in the hippocampus,
amygdala, and neocortex revealed that these neurons in the
forebrain represent a subgroup of excitatory glutamatergic
neurons called nowadays as gluzinergic neurons [7, 8].
Neurons that contain free Zn ions in the vesicles of their
presynaptic boutons are present also in other brain areas and
are generally termed Zn-enriched (ZEN) neurons. In the
spinal cord, it has been proven that the majority of ZEN
terminals are inhibitory g-aminobutyric acid (GABA)-ergic,
and only a minor pool is glutaminergic [9]. Glycinergic
ZEN neurons in the spinal cord have also been described,
and recently, the presence of GABAergic ZEN terminals has
been found in the cerebellum [10]. Releasable, vesicular Zn
is most abundant in brain regions that are prone to seizures,
namely the limbic regions. Potential roles for synaptic re-
leased Zn include inhibition of NMDA receptors, potentia-
tion of AMPA receptor responses, inhibition epileptics, in
which plasma Mg concentrations decreased of GABAA
receptors that lack γ subunits, and antagonism of voltage-
gated calcium channels. Thus, as a potential neuromodula-
tor, Zn is capable of exerting effects that could either inhibit
or promote neuronal excitability, suggesting the possibility
of both pro- and anticonvulsant properties [7, 11].
Therefore, Zn homeostasis in the brain may be important
for the development of seizures. In some studies, Zn showed
anticonvulsant effect, although Zn has a proconvulsant effect
depending on the type of seizure, animal species, and convul-
sant agents [12, 13]. Systemic charges of Zn have shown
anticonvulsant property in several experimental models [12].
Lynes et al. characterized Zn as an agent modifying reac-
tive oxygen species activation, increasing oxidative activity of
NADPH, and consequently, triggering oxidative stress [14].
Zn is also cofactors of some antioxidant enzymes such as
superoxide dismutase and catalase [15]. It was found that the
development of such attacks is related to oxidative stress
within the brain In addition, oxidative stress represents one
of the crucial factors providing greater BBB permeability
values during epileptic seizures [16]. Therefore, antioxidant
levels may be important during seizures
The effect of Zn treatment on convulsions is controversial,
and its effect on the BBB permeability is not known. Seizure
activity in epileptic patients and experimental models of epi-
lepsy influence the metabolism of essential trace elements,
e.g., Zn, Fe, Cu, andMg in the brain and peripheral tissues [5].
It is important to show whether the concentration of essential
elements in the brain is altered by enhancement of suscepti-
bility to seizures or epileptic neuronal activity. For these
reasons, the aim of the present study was to investigate the
role of chronic Zn treatment on the BBB permeability in
pentylenetetrazole (PTZ)-induced seizures and levels of other
elements in the different brain regions.
Materials and Methods
Animals
The experimental procedure was in accordance with the
Helsinki Declaration (2004). The 32 Wistar albino rats were
divided into four groups as follows: (1) control group, (2)
pentylenetetrazole (Sigma Cat no. P6500) group: rats treated
with PTZ (80 mg/kg, i.v.) to induce epileptic seizures, (3) Zn
group: rats treated with ZnCl2 227 ml/kg [17] added to
drinking water for 2 months, and (4) Zn+PTZ group. Can-
nulations of the femoral artery and vein were performed in
animals. The blood pressure was measured from the femoral
artery. PTZ and Evans blue were injected from the femoral
vein. Because most anesthetics have anticonvulsant proper-
ties, diethyl ether anesthesia was used.
Assessment of Blood–Brain Barrier Permeability
Evans Blue (Sigma Cat no. E-2129) was used as BBB tracer
(4 ml/kg, i.v.). PTZ was i.v. injected in order to induce
convulsions, 5 min after Evans Blue injection. The brains
were elutriated by perfusion with 0.9 % NaCl solution via
the left ventricle 25 min after Evans Blue injection. Then,
the brains were dissected and separated into the left hemi-
sphere, right hemisphere, and cerebellum+brainstem
regions. Wet masses of the dissected samples were mea-
sured. Afterwards, each brain region was homogenized by
placing in tubes with phosphate buffer (2.5 ml). A 60 %
solution of trichloroacetic acid (2.5 ml) was put in each tube
after homogenizing; this procedure provided separation of
Evans Blue from albumin by vortexing for 2 min. After the
vortex process, the tubes were kept at 4 °C for 30 min and
centrifuged at 1,000×g at 4 °C for 30 min. After centrifug-
ing, the absorbance values were read spectrophotometrically
at 620 nm wavelength (after decanting supernatants to spec-
trophotometer tubes). The Evans Blue content values
(micrograms per milligram tissue) were calculated for brain
tissue samples using the Evans Blue absorbance-quantity
regression equation and catenary via the obtained absor-
bance values. The statistical analysis was made with SPSS
(Statistical Package for Social Sciences 16.0 version).
Measurement of Element Concentrations
Samples of 0.2 g. were taken and transferred into Teflon
vessels and then 10 ml of 20 % HNO3 (Merck) was added.
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Samples were mineralized in a microwave oven (Berghof–
MWS2) as follows: at 145 °C for 5 min, at 165 °C for 5 min,
and at 175 °C for 20 min. After cooling, the samples were
filtered by Whatman filters, and filled up to 50 ml with
ultrapure water in volumetric flasks and then stored in
falcon tubes. Standard solutions were prepared by using
multi-element stock solutions—1,000 ppm (Merck), and
element (Cu, Mg, Na, and Zn) measurements were done
by inductively coupled plasma optical emission spectrosco-
py (PerkinElmer-Optima 7000 DV).
Statistical Analysis
The obtained data were analyzed with SPSS (version
17.0) statistics program. Evans Blue–albumin extravasa-
tion, arterial pressure, and element concentration were
expressed as mean±standard deviation. Data were com-
pared among groups and brain regions using one-way
analysis of variance and subsequently Tukey’s test was
performed (P<0.05).
Results
Systolic and diastolic blood pressures are shown in Table 1.
PTZ-induced convulsions caused a significant increase in
the blood pressure in groups 2 and 4 (P<0.001).
In control animals (group 1), the mean Evans Blue con-
centrations in both cerebral hemispheres and in the cerebel-
lum+brainstem regions were 0.31±0.09, 0.31±0.08, 0.37±
0.07 (mean±SD)μg/mg tissue, respectively. The BBB per-
meability increased significantly in the PTZ group [0.62±
0.15, 0.65±0.11, 0.88±0.18 (mean±SD)μg/mg tissue, re-
spectively]. The mean Evans Blue concentration in the Zn
group is [0.42±0.06, 0.47±0.14, 0.76±0.10 (mean±SD)μg/
mg tissue, respectively] and [0.72±0.11, 0.70±0.13, 0.75±
0.16 (mean±SD)μg/mg tissue, respectively] in the Zn+PTZ
groups (P<0.05 and P<0.01; Fig. 1).
There was no significant difference between the con-
trol and Zn+PTZ groups (P>0.05). In both the Zn and
PTZ groups, the mean Evans Blue concentration of
cerebellum+brainstem increased compared to cerebral
hemispheres (P <0.05, P<0.01, and P<0.001; Fig. 1).
Zn concentrations were significantly increased in all
brain regions and in all groups compared to control group
(P<0.01 and P<0.05). Additionally, it increased in all the
brain regions of the Zn+PTZ group compared to PTZ and
Zn groups (P<0.05; Fig. 2).
Zn concentration of cerebellum+brainstem significantly
increased when compared to right hemisphere in the control
group (P<0.05). It was significantly high in brain hemi-
spheres when compared to cerebellum+brainstem (P<0.01),
and also, Zn concentration of the left hemisphere was signif-
icantly higher than the right hemisphere (P<0.05).
Zn concentration of the left hemisphere in Zn group was
higher than the cerebellum+brainstem and right hemisphere
(P<0.05 and P<0.01). In the Zn and PTZ groups, Zn
concentration of the left and right hemispheres increased
compared to cerebellum+brainstem regions (P<0.05 and
P<0.01; Fig. 2).
Significant increases of Na content in all groups were
observed (P<0.001; Fig. 3). In the control group, Na level in
cerebellum+brainstem was higher than the left hemisphere
(P<0.01) and significantly increased in the left hemisphere
compared to the right hemisphere (P<0.01). In the PTZ and
Zn group, Na concentration of the left hemisphere increased
compared to the right hemisphere (P<0.01). In the Zn
group, Na concentration of the left hemisphere increased
compared to the cerebellum+brainstem (P<0.05). In the Zn
and Zn+PTZ groups, Na concentration of cerebellum+
brainstem region increased compared to the right hemi-
sphere (P<0.05; Fig. 3).
A significant reduction of Mg content in all the brain
regions was observed in Zn-treated groups compared to
other groups (P<0.001; Fig. 4). Mg level was found high
in the cerebellum+brain stem when compared to cerebral
hemispheres and found high in the right hemisphere in the
PTZ group (P<0.05 and P<0.01).
In the Zn-treated group, Mg level in the right hemisphere
increased compared to the left hemisphere and the cerebel-
lum+brainstem (P<0.05 and P<0.01). In the Zn+PTZ
group, Mg concentration of the left hemisphere was higher
Table 1 Before and after PTZ, values of arterial blood pressure for experimental groups
Groups n Diastolic pressure (mmHg) Systolic pressure (mmHg) Diastolic pressure (mmHg) Systolic pressure (mmHg)
Before PTZ Before PTZ After PTZ After PTZ
Control 8 80±3 100±5 − −
PTZ 8 72±2 92±6 148±9 170±10
Zn 8 76±5 96±8 − −
Zn+PTZ 8 88±4 108±3 142±9 152±12
*P<0.001, significant difference from control group
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than the right hemisphere (P<0.05; Fig. 4). Cu content in all
the brain regions was significantly decreased in all groups
compared to the control (P<0.01 and P<0.001; Fig. 5).
In the control group, Cu concentration of cerebellum+
brainstem increased compared to cerebral hemispheres (P<
0.01 and P<0.001). In the Zn group, Cu concentration of the
right hemisphere increased compared to the cerebellum+
brainstem region (P<0.05 and P<0.01). Cu concentration
of the left and right hemispheres increased compared to the
cerebellum+brainstem regions in Zn+PTZ group (P<0.05).
Discussion
In our study, we observed that BBB permeability signifi-
cantly increased in the PTZ group as shown in numerous
studies [18]. We found that BBB breakdown is significantly
higher than cerebral hemispheres. Arnaiz et al. [19] showed
that the cerebellum is more susceptible to epileptic seizures,
and its antioxidant capacity is lower than cerebral cortex,
and brain imaging studies in human have shown that cere-
bral metabolic rate of glucose consumption is high in the
occipital cortex and cerebellum The increased metabolism

















Fig. 1 Displaying Evans Blue (EB) amounts in the left and right
hemispheres and cerebellum+brain stem of the groups and within
groups (control group 1, PTZ group 2, Zn group 3, Zn+PTZ group
4). One star shows a significant difference (P<0.05). One cross shows
a significant difference (P<0.01). Control vs. other groups and the
region of the brain within groups
























Fig. 2 Amounts of Zn (milligrams per kilogram tissue) in samples of
the left brain hemisphere, right hemisphere, and cerebellum+brainstem
regions in groups 1–4 of experimental rats and within groups (control
group 1, PTZ group 2, Zn group 3, Zn+PTZ group 4). Intragroup
means±SD are shown. One cross shows a significant difference (P<
0.01). One star shows a significant difference (P<0.05). Control vs
experimental groups. Zn+PTZ group vs Zn and PTZ group and the
region of the brain within groups


























Fig. 3 Amounts of Na (milligrams per kilogram tissue) in samples of
the left brain hemisphere, right hemisphere, and cerebellum+brainstem
regions in groups 1–4 of experimental rats and within groups (control
group 1, PTZ group 2, Zn group 3, Zn+PTZ group 4). Intragroup
means±SD are shown. One asterisk shows cases of significant differ-
ences (P<0.001) One cross shows a significant difference (P<0.01).
Control vs experimental groups. Zn+PTZ group vs Zn and PTZ group
and the region of the brain within groups


















Fig. 4 Amounts of Mg (milligrams per kilogram tissue) in samples
of the left brain hemisphere, right hemisphere, and cerebellum+
brainstem regions in groups 1–4 of experimental rats (control
group 1, PTZ group 2, Zn group 3, Zn+PTZ group 4) and within
groups. Intragroup means±SD are shown. One asterisk shows
cases of significant differences (P<0.001) Control vs experimental
groups and the region of the brain within groups
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caused by high firing rates of the cerebellum neurons may
provoke more free radical production during epileptic seiz-
ures. These factors can be a reason for high Evans Blue values
in comparing to brain hemispheres in the PTZ group [19].
Also, chronic Zn supplementation for 2 months increased
BBB permeability during convulsions. These results dem-
onstrated that BBB was severely damaged in both Zn-
supplemented and not supplemented epileptic animals. Sev-
eral reports suggested that the body electrolytes Na+, K+,
Ca2+, and Mg2+ and the level of some trace elements play a
vital role for seizure conditions to develop [20, 21]. It is
known that Zn is a vital nutrient, and with the exception of
iron, it is the most abundant trace element in the body. Zn
released from neuron terminals serves a neuromodulatory
function, as suggested by the multiple selective actions of
Zn on synaptic function and the potency of Zn ions to
modulate numerous neurotransmitter receptors such as
GABA, NMDA, and ion channels [5, 9, 22]. As a potential
neuromodulator, Zn is capable of exerting effects that could
either inhibit or promote neuronal excitability, suggesting
the possibility of both pro- and anti-convulsant effects [23,
24]. In this study, Zn supplementation for 2 months did not
show a protective effect on increased BBB permeability
during convulsions. Moreover, there was no change in se-
verity and duration of seizure intensity and arterial blood
pressure between animals treated with Zn and those that
were not treated with Zn. In parallel with our results, mice
that are lacking vesicular Zn (pharmacologically or geneti-
cally) or rats that are fed a Zn-deficient diet have been
shown to be more susceptible to kainate-induced seizures
and show an increase in seizure severity and duration [25].
Conversely, intracerebral or intrahippocampal injections of
Zn have been shown to cause partial and secondarily gen-
eralized seizures in rabbits [26, 27]. Taken together, these
data indicate that alterations of Zn homeostasis contribute to
the development of epileptic seizures. These contradictions
are probably related to the fact that Zn manifests dissimilar
effects depending on the type of application form, doses,
and duration.
We found that Zn by itself also caused BBB breakdown
without seizures. We think that Zn might cause an imbal-
ance between ionic homeostasis in the brain. Significant
increases of Zn amount in all brain regions under study were
observed in all groups compared to the control group.
Moreover, Zn concentration significantly increased in the
Zn+PTZ group compared to PTZ and Zn groups. Studies in
hippocampus, amygdale, and neocortex showed that the
neurons in these regions represent a group of excitatory
gluzinergic neurons neurons It has been shown that most
of the Zn in these Zn-enriched neurons are found in their
presynaptic boutons [7, 8]. In addition to Zn released from
neuron terminals, chronic Zn treatment may cause Zn accu-
mulation. In our results, there is a correlation between Zn
levels and Evans blue values in PTZ and Zn+PTZ groups.
According to this result, Zn accumulation may provoke
BBB breakdown during epileptic seizures. Zn is a potent
Na-K-ATPase inhibitor. Barbeau et al. showed that intra-
cerebroventricular Zn inhibited Na-K-ATPase and resulted
in convulsions by increasing cerebrospinal fluid potassium
levels [27]. Inhibiting Na-K-ATPase in cerebral endothelial
cells may be a significant reason for BBB damage.
On the other hand, we found a significant decrease in Cu
levels in all experimental groups. Cu is an essential trace
element in all living organisms. It is mainly a part of the
active center of cuproenzymes, such as cytochrome c oxi-
dase—a component of the mitochondrial respiratory chain
[28]. One of the symptoms of Cu deficiency includes de-
creased superoxide dismutase, ceruloplasmin as well as
cytochrome-c oxidase [29]. During epileptic seizures, free
radical production is increased and insufficiency in antiox-
idant defence mechanisms could provoke BBB breakdown
and neuronal damage. Sahin et al. [30] have shown de-
creased levels of Cu and Fe in brain tissue and increase in
BBB permeability in the repeated seizures group. It has been
shown that taking large doses of supplemental Zn over
extended periods of time has shown to be associated with
Cu deficiency [31]. These findings are parallel with our
results. When we consider that free radical levels are in-
creased in epileptic seizures, the antioxidant defense system
in epileptic animals might remain insufficient in these
groups because of Cu deficiency.
We found a significant increase in the amount of Na in
the three brain regions of all the groups. Also, it was found
that Na level was increased in the Zn+PTZ group compared
to the PTZ and Zn groups. It was shown that brain shrinkage


















Fig. 5 Cu (milligrams per kilogram tissue) in samples of the left brain
hemisphere, right hemisphere, and cerebellum+brainstem regions in
groups 1–4 of experimental rats (control group 1, PTZ group 2, Zn
group 3, Zn+PTZ group 4) and within groups. Intragroup means±SD
are shown. One asterisk shows cases of significant differences (P<
0.001) One cross shows a significant difference (P<0.01). Control vs
experimental groups and the region of the brain within groups
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induced by hypernatremia can cause rupture of cerebral
veins, with focal intracerebral and subarachnoid hemor-
rhages, which in turn can provoke seizures [32]. Seizures
also occur in ≤40 % of patients treated for severe hyper-
natremia by rapid infusion of hypotonic solutions [33]. In
our study, Mg2+ was unaltered in all brain regions in the
PTZ group, and this is consistent with many studies [34].
Mg2+ is essential in neuronal excitability. It alters Ca2+
mobilization and stabilizes excitable membranes and also
exerts a voltage-dependent blockage of the NMDA-receptor
channel [35]. In human beings hypomagnesemia is associated
with manifestations of central nervous system dysfunction
[36]. Mg2+ levels in all the brain regions were decreased in
the Zn group and Zn+PTZ groups compared to other groups.
Decreased Mg2+ level may contribute to BBB damage.
During convulsions, Zn treatment did not show a protec-
tive effect on the BBB permeability. Also, we have shown
that Zn has adverse effects on the BBB via changing Mg,
Cu, Na, and Zn levels. Chronic Zn treatment by itself
decreased Mg and Cu concentration and increased Na levels
in brain tissue and during seizures and non-seizures. As a
result of that, changes in prooxidant/antioxidant balance and
neuronal membrane excitability may contribute to BBB
damage. Our study showed that Zn treatment showed pro-
convulsant activity during seizures.
There is a neurochemical asymmetry as well as function-
al asymmetry in the brain [37]. It may be the underlying
reason for difference in element levels in the control group.
However, there are more fluctuations in element levels in
the experimental groups. Brain hemispheres manifest differ-
ent neurochemical changes against either extra supplemen-
tation of an element such as Zn or a pathological condition
such as epilepsy. These neurochemical changes also affect
element levels important for electrical activity of the brain.
The cause of these differences can be revealed more pre-
cisely by molecular studies.
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